Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 13 of 13 entries
View as:

A First-in-Human Multi-Part Phase 1 Study in Healthy Volunteers to Evaluate the Safety, Tolerability, Pharmacokinetics, and Drug-Drug Interaction Potential of Single and Multiple Doses of ALG-097558

Phase: N/A Priority: Normal
NCT ID: NCT05840952 Org: User:
Start: 07/04/23 End: 04/29/24 Due: 04/29/25

A Phase 1 Study in Healthy Volunteers to Evaluate the Relative Bioavailability of ALG-055009 Formulations

Phase: N/A Priority: Normal
NCT ID: NCT06959888 Org: User:
Start: 03/25/25 End: 05/08/25 Due: 05/08/26

A Study of ALG-055009 in Healthy Volunteers and Subjects With Hyperlipidemia

Phase: N/A Priority: Normal
NCT ID: NCT05090111 Org: User:
Start: 12/01/21 End: 06/16/23 Due: 06/16/24

A Study of ALG-010133 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04485663 Org: User:
Start: 08/17/20 End: 03/08/22 Due: 03/08/23

A Phase 1 Study to Evaluate the Drug-Drug Interaction Potential Between ALG-055009 and Statin Therapy(Ies)

Phase: N/A Priority: Normal
NCT ID: NCT06191991 Org: User:
Start: 11/03/23 End: 12/04/23 Due: 12/04/24

A Study of ALG-000184 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single and Multiple Doses in Healthy Volunteers and CHB Subjects

Phase: N/A Priority: Normal
NCT ID: NCT04536337 Org: User:
Start: 10/22/20 End: 06/16/25 Due: 06/16/26

ALG-055009 in Non-cirrhotic Adults With MASH (HERALD)

Phase: N/A Priority: Normal
NCT ID: NCT06342947 Org: User:
Start: 04/01/24 End: 09/09/24 Due: 09/09/25

A Study of ALG-020572 Drug to Evaluate Safety, Tolerability, Pharmacokinetics and Pharmacodynamics After Single Doses in Healthy Volunteers and Multiple Doses in CHB Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05001022 Org: User:
Start: 09/25/21 End: 07/18/22 Due: 07/18/23

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects with Hepatic Impairment and in Healthy Subjects with Normal Hepatic Function

Phase: N/A Priority: Normal
NCT ID: NCT06568861 Org: User:
Start: 01/14/25 End: 05/31/25 Due: 05/31/26

A Study to Evaluate the Pharmacokinetics, Safety and Tolerability of ALG-097558 in Subjects with Renal Impairment and in Healthy Subjects with Normal Renal Function

Phase: N/A Priority: Normal
NCT ID: NCT06698549 Org: User:
Start: 02/01/25 End: 02/28/26 Due: 02/28/27

A Study of ALG-125755 to Evaluate Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics After Single Doses in Healthy Volunteers, and Single and Multiple Doses in CHB Subjects

Phase: N/A Priority: Normal
NCT ID: NCT05561530 Org: User:
Start: 10/07/22 End: 06/15/23 Due: 06/15/24

A Study Evaluating the Efficacy and Safety of ALG-000184 Compared With Tenofovir Disoproxil Fumarate in Untreated HBeAg-Positive and HBeAg- Negative Adult Subjects With Chronic Hepatitis B (B-SUPREME)

Phase: N/A Priority: Normal
NCT ID: NCT06963710 Org: User:
Start: 05/31/25 End: 08/31/28 Due: 08/31/29

A Multi-part Study of ALG-000184 to Evaluate Safety, Tolerability, Pharmacokinetics and Drug-drug Interaction Potential After Single and Multiple Doses in Healthy Volunteers

Phase: N/A Priority: Normal
NCT ID: NCT06672900 Org: User:
Start: 01/09/25 End: 07/07/25 Due: 07/07/26